Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Inflazyme Pharmaceuticals (T.IZP) -- Ignore unavailable to you. Want to Upgrade?

To: Harold Lehman who wrote (1120)	11/30/1998 4:59:00 PM
From: Amanda Marley-Clarke	Read Replies (1) \| Respond to of 1501

Hi Harold, I enjoyed your TB article...I forwarded it to a few people I know who are still holding on. I really hope the company can do something with all the promising drugs they have. It would be great to see the stock turn around - especially for all the long term shareholders. On another note, remember Rashid Aziz? He was the CFO at IZP, back in the good 'ole days of better prices. He has a new deal on the VSE called IX Capital (one of these new VCP-venture capital pools) which trades around 40-44 cents. The symbol is IXI. It came public October 1st and they have 2.2 million shares out (most of that held by Directors - I think there's about a 500,000 share float). They also have $500,000 in the bank and are looking for a deal to put into the company. The Board of Directors looks good too. One of the other directors, David Clark, used to be a director for IZP. They also have the President of IGT (a VSE company with an anti-cancer compound), Bruce Schmidt, as a director. Just thought you might be interested in what some of the ex-IZP'ers were up to. Thanks again for your informative posts. Take care, Amanda